| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |